Insider · CIK 0001607052
Huber Reid M
Reports to the SEC for 5 companies · BOSTON, MA
Transactions
50
Companies
5
Filings
18
CIK
0001607052
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-10 | RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-09-12 | RAPPRapport Therapeutics, Inc.P Purchase | +$499K |
| 2025-08-19 | CARGO Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-06-18 | CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2025-06-17 | RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-04 | CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-11-09 | CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-06-06 | TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-06 | TNGXTango Therapeutics, Inc.A Award | — |
| 2023-01-03 | BELLICUM PHARMACEUTICALS, INCM Exercise/Conversion | — |
| 2023-01-03 | BELLICUM PHARMACEUTICALS, INCM Exercise/Conversion | — |
| 2022-09-01 | BELLICUM PHARMACEUTICALS, INCM Exercise/Conversion | — |
| 2022-06-15 | BELLICUM PHARMACEUTICALS, INCStock Option (right to buy)A Award | — |
| 2022-06-08 | TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-01-04 | BELLICUM PHARMACEUTICALS, INCM Exercise/Conversion | — |
| 2022-01-04 | BELLICUM PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2021-06-15 | BELLICUM PHARMACEUTICALS, INCStock Option (right to buy)A Award | — |
| 2021-01-04 | BELLICUM PHARMACEUTICALS, INCRestricted Stock UnitsA Award | — |
| 2020-06-15 | BELLICUM PHARMACEUTICALS, INCStock Option (right to buy)A Award | — |
| 2019-06-13 | BELLICUM PHARMACEUTICALS, INCStock Option (right to buy)A Award | — |
| 2018-07-16 | INCYINCYTE CORPF Tax Payment | −$31.4K |
| 2018-07-05 | INCYINCYTE CORPF Tax Payment | −$19.4K |
| 2018-07-02 | INCYINCYTE CORP · Employee Stock Option (right to buy)A Award | — |
| 2018-06-14 | BELLICUM PHARMACEUTICALS, INCStock Option (right to buy)A Award | — |
| 2018-02-21 | INCYINCYTE CORPS Sale | −$168K |
| 2018-02-20 | INCYINCYTE CORPF Tax Payment | −$91.5K |
| 2018-01-24 | INCYINCYTE CORP · Employee Stock Option (right to buy)A Award | — |
| 2018-01-23 | INCYINCYTE CORP · Employee Stock Option (right to buy)A Award | — |
| 2017-12-01 | INCYINCYTE CORPS Sale | −$68.2K |
| 2017-09-13 | INCYINCYTE CORPF Tax Payment | −$85.2K |
| 2017-07-05 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award | — |
| 2017-07-05 | INCYINCYTE CORPA Award | — |
| 2017-06-14 | BELLICUM PHARMACEUTICALS, INCStock Option (right to buy)A Award | — |
| 2017-05-08 | INCYINCYTE CORPS Sale | −$1.02M |
| 2017-05-05 | INCYINCYTE CORPF Tax Payment | −$967K |
| 2017-02-27 | INCYINCYTE CORPS Sale | −$265K |
| 2017-01-17 | INCYINCYTE CORP · Incentive Stock Option (right to buy)A Award | — |
| 2017-01-17 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award | — |
| 2017-01-17 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award | — |
| 2017-01-09 | INCYINCYTE CORPS Sale | −$1.33M |
| 2016-11-09 | INCYINCYTE CORPS Sale | −$299K |
| 2016-10-07 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2016-10-07 | INCYINCYTE CORPM Exercise/Conversion | +$215K |
| 2016-10-07 | INCYINCYTE CORPS Sale | −$1.13M |
| 2016-08-02 | INCYINCYTE CORPS Sale | −$880K |
| 2016-07-15 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award | — |
| 2016-07-15 | INCYINCYTE CORPA Award | — |
| 2016-06-15 | BELLICUM PHARMACEUTICALS, INCStock Option (right to buy)A Award | — |
| 2016-02-24 | INCYINCYTE CORPF Tax Payment | −$133K |
| 2016-02-16 | INCYINCYTE CORPM Exercise/Conversion | +$98.5K |
Recent filings
- 4Huber Reid M0001193125-26-266090SEC(opens sec.gov)
- 4Huber Reid M0001193125-25-203540SEC(opens sec.gov)
- 4Huber Reid M0001610717-25-000299SEC(opens sec.gov)
- 4Huber Reid M0001610717-25-000249SEC(opens sec.gov)
- 4Huber Reid M0000950170-25-087899SEC(opens sec.gov)
- 4Huber Reid M0001610717-24-000299SEC(opens sec.gov)
- 4Huber Reid M0001610717-23-000345SEC(opens sec.gov)
- 4Huber Reid M0000899243-23-015015SEC(opens sec.gov)
- 4/AHuber Reid M0001628280-23-001321SEC(opens sec.gov)
- 4Huber Reid M0001628280-23-000420SEC(opens sec.gov)
- 4Huber Reid M0001628280-22-024218SEC(opens sec.gov)
- 4Huber Reid M0000899243-22-024396SEC(opens sec.gov)
- 4Huber Reid M0001628280-22-017337SEC(opens sec.gov)
- 4Huber Reid M0001628280-22-000416SEC(opens sec.gov)
- 4Huber Reid M0001209191-21-045944SEC(opens sec.gov)
- 4Huber Reid M0001628280-21-000097SEC(opens sec.gov)
- 4Huber Reid M0001628280-20-009547SEC(opens sec.gov)
- 4Huber Reid M0001358403-19-000092SEC(opens sec.gov)
Companies
Address
RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100
BOSTON, MA, 02110